ClinicalTrials.Veeva

Menu

Natives Engaged in Alzheimers Research - 'Ike Kupuna (NEAR)

University of Hawaii logo

University of Hawaii

Status

Enrolling

Conditions

Mild Cognitive Impairment
Subjective Cognitive Impairment

Treatments

Behavioral: Ola Mau i ka Hula

Study type

Interventional

Funder types

Other

Identifiers

NCT05534607
'Ike Kupuna

Details and patient eligibility

About

This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.

Full description

This study will conduct a pragmatic group-randomized trial (GRT) with NHPIs aged 50-75 years with at least 1 of 4 modifiable vascular risk factors for ADRD (hypertension, hyperglycemia, obesity, or dyslipidemia) and either SCI or MCI using a wait-list control design to test the effects of the hula-based intervention. The primary outcomes will be vascular risk factors for ADRD and subjective cognitive complaints. Secondary outcomes will include measures of cognitive performance, physical function, and mental health.

Enrollment

192 estimated patients

Sex

All

Ages

50 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. self-reported Native Hawaiian or other Pacific Islander ancestry;
  2. ages 50+ but not older than 75 (optimal age range for preventing future dementia in people with cognitive impairment, above 75 is not likely to benefit from this study given their advance age);
  3. has subjective cognitive impairment (SCI) or mild cognitive impairment (MCI);
  4. have a diagnosis of hypertension, diabetes, dyslipidemia, or obesity (body-mass-index ≥ 30 kg/m2);
  5. physically able and willing to engage in moderate physical activity necessary for Hula; and
  6. physician's approval to participate in moderate physical activity

Exclusion criteria

  1. currently pregnant;
  2. already actively practicing Hula at least once per week; or
  3. clinical diagnosis of ADRD (mild to severe); or
  4. current diagnosed major depressive disorder at moderate or greater stage, or moderate or greater depression on the Center for Epidemiological Studies Depression Scale (CES-D).

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

192 participants in 2 patient groups

Intervention group
Experimental group
Description:
The intervention group will immediately receive the Ola Mau i ka Hula intervention after randomization for 12 months. The intervention program is 8 months with a 4 month self-monitoring period.
Treatment:
Behavioral: Ola Mau i ka Hula
Wait-list control group
No Intervention group
Description:
After baseline data collection, participants randomized to the wait-list control arm will not receive the Ola Mau i ka Hula Program while their counterparts who were randomized to the intervention arm are undergoing the intervention program. Thus, they will not be offered the intervention until after the intervention arm is completed and their 12-month follow-up data collection is completed. They will only receive the educational component of the intervention from us during this 12-month period but they will be instructed to continue with their routine medical care as usual. Wait-list control group will be offered the opportunity to receive intervention at the conclusion of 12 month assessment period, regardless of whether they were retained for the full 12 months of data collection.

Trial contacts and locations

3

Loading...

Central trial contact

Janice K Worthington, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems